Related Experiment Videos
Translational research in breast cancer
Masakazu Toi1, Yuji Takebayashi, Louis W Chow
1Department of Clinical Trials and Research, Metropolitan Komagome Hospital, Tokyo Metropolitan Cancer and Infectious Disease Centre, 3-18-22, Honkomagome Bunkyo-ku, Tokyo, 113-8677, Japan. maktoi77@wa2.so-net.ne.jp
Breast Cancer (Tokyo, Japan)
|April 29, 2005
Summary
Translational research (TR) drives innovation in cancer care by linking novel diagnostics and therapeutics. This process accelerates the development of new treatments and enhances clinical trial efficiency for personalized medicine.
Area of Science:
- Oncology
- Translational Research
- Biomedical Science
Background:
- Translational research (TR) integrates diagnostic and therapeutic development.
- These advancements create new paradigms for cancer patient management.
- Examples include Her-2 assessment and trastuzumab therapy for breast cancer.
Purpose of the Study:
- To highlight the critical role of translational research in oncology.
- To emphasize the importance of TR in developing novel therapeutics.
- To discuss how TR accelerates innovation in cancer treatment.
Main Methods:
- Review of existing literature on translational research in oncology.
- Analysis of the association between diagnostic and therapeutic development.
- Examination of the impact of TR on clinical trial design and efficiency.
Main Results:
- TR acts as a catalyst for novel treatment paradigms.
- The integration of diagnostics and therapeutics leads to individualized treatment systems.
- Prospective clinical trials are essential for effective TR.
Conclusions:
- Translational research is crucial for advancing cancer care.
- TR accelerates the development and efficiency of novel therapeutics.
- Implementing TR in clinical trials is key to personalized oncology.